← Open Payments lookup

ERNEST GRAYPEL: Open Payments

NPI 1265723407 · ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,087 in 100 payments from 17 companies in 2025. Trend: 2023 $1,530 · 2024 $1,972 · 2025 $2,087

Food & beverage: $2,087
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$451
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$403
Alkermes, Inc.10$226
Alpha Cognition USA, Inc.6$190
Axsome Therapeutics, Inc.9$149
Takeda Pharmaceuticals U.S.A., Inc.8$149
Otsuka America Pharmaceutical, Inc.8$137
Vanda Pharmaceuticals Inc.4$99
Neos Therapeutics, LP3$55
Almatica Pharma LLC3$50

Products named: INGREZZA, CAPLYTA, ARISTADA, Zunveyl, REXULTI, Auvelity, TRINTELLIX, FANAPT.

Industry payments across MO — which companies pay providers there.